Associate Chief Physician. He specializes in minimally‑invasive and standardized surgical treatment for gastrointestinal tumors.
He has long been committed to research on scientific issues related to gastric tumors. In recent years, his research has focused on exploring predictive biomarkers and investigating drug‑resistance mechanisms for chemotherapy, targeted therapy and immunotherapy of gastric cancer. He has participated in three projects including those supported by the National Natural Science Foundation of China and the Science and Technology Commission of Shanghai Municipality. As corresponding author and first author, he has published more than 10 SCI papers in internationally‑renowned oncology journals in recent years, such as Annals of Oncology, Annals of Surgery, Oncoimmunology, Cell Death Discov, World J Gastroenterol and BMC Cancer, with a cumulative impact factor of 108.396.
English